Roots Global
Lince Capital logo
Venture CapitalFully subscribed

Lince Innovation Fund II

Fully subscribed Lince Capital fund financing R&D-driven Portuguese companies in tech and healthcare; ~€69.7M raised across two subfunds.

Managed by Lince Capital · Av. Eng.º Duarte Pacheco, Torre 2, Piso 17, 1070-102 Lisbon, Portugal

Key facts

€100k
Minimum investment
Management fee p.a.
Lock-up
Target return
Fund status
Fully subscribed
Redemption
~At end of term2
NAV frequency
Performance fee
Hurdle rate
Subscription fee
Redemption fee
Fund size
~€69.7M2
Target size
Inception
Fund term
8 years1
Distribution
CMVM ID
ISIN
Legal structure
Closed-end fund with two subfunds (Subfund I and Subfund II), per the manager's funds page2
Domicile
Portugal2
Custodian
Auditor

For US investors

US investors accepted
PFIC status
Annual QEF statements
IRA / 401(k) route

No public information on US investor acceptance. As a non-US pooled fund it would be expected to be a PFIC for US taxpayers; no QEF information published. The fund is closed to new subscriptions, so this is largely moot for new investors.

Fees & costs

Management fee p.a.
Performance fee
Hurdle rate
Subscription fee
Redemption fee

Performance

No audited performance data is publicly available for this fund yet. We only show returns we can trace to fund reporting — never marketing projections presented as track record.

Documents

  • Lince Capital — Investment Funds (Innovation Fund II Subfund I & II cards)

    Manager website · EN · accessed Jul 7, 2026

    Open

Data transparency

Researched Jul 7, 2026 · every fact carries its source

31%
data completeness

Still researching

  • Management fee
  • Performance fee
  • Lock-up period
  • CMVM registration
  • US investor acceptance
  • ISIN
  • Target fund size
  • Inception date
  • NAV frequency
  • Hurdle rate
  • Subscription fee
  • Redemption fee
  • Custodian
  • Auditor
  • Target return
  • Distribution policy
  • PFIC status
  • QEF reporting
  • IRA/401(k) eligibility
  • Portfolio allocation

Sources

  1. 1Lince Innovation Fund II — Nomad Gate profile Nomad Gate (aggregator), accessed Jul 7, 2026
  2. 2Lince Capital investment funds overview (subscribed capital per subfund) Lince Capital (manager), accessed Jul 7, 2026

Research summary

Compiled from the sources cited on this page — a factual summary, not a recommendation or rating.

Lince Innovation Fund II was Lince Capital's Golden Visa-oriented R&D vehicle, financing Portuguese companies focused on innovation and research & development in the technology and healthcare sectors. It sits between Innovation Fund I (€36M, health/tech/industrial) and the much larger Innovation Fund III (€146M) in the Lisbon manager's fund lineage. The fund was structured in two subfunds, which Lince's site shows as fully subscribed with €64.6M (Subfund I) and €5.1M (Subfund II) of capital — roughly €69.7M combined.

Subscriptions ended in August 2024 per Nomad Gate, whose profile records a €100,000 minimum ticket and an 8-year duration; a fund representative had confirmed continued Golden Visa eligibility under the post-October 2023 rules, credible given the non-real-estate R&D mandate (unlike several of Lince's property-flavoured funds). No fee schedule, ISIN, CMVM number or performance data is public. The profile is retained for reference; investors interested in the strategy today would look at Lince's open successor funds.

Suited for

  • ·Reference only — both subfunds are fully subscribed (subscriptions ended August 2024)
  • ·Useful as background on Lince Capital's Innovation fund series when evaluating its currently open funds

Risk factors

  • ·Closed-end ~8-year structure — capital locked until term with no published interim liquidity
  • ·Venture/R&D financing risk concentrated in Portuguese tech and healthcare companies
  • ·Minimal public disclosure: no fees, ISIN, CMVM number or performance data published

Listed for completeness, drawn from fund materials and public sources — not an assessment. How much weight any factor deserves depends on your own situation and risk appetite.

Tom Brooks

Tom Brooks

Founding Partner & CEO

Talk through Lince Innovation Fund II and how it fits your Golden Visa plan — independent guidance, no obligation.

Book a free consultationor email hello@rootsglobal.com